Fresenius Medical Care Stock Last Dividend Paid
FMS Stock | USD 20.55 1.01 5.17% |
Fresenius Medical Care fundamentals help investors to digest information that contributes to Fresenius Medical's financial success or failures. It also enables traders to predict the movement of Fresenius Stock. The fundamental analysis module provides a way to measure Fresenius Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fresenius Medical stock.
Fresenius |
Fresenius Medical Care Company Last Dividend Paid Analysis
Fresenius Medical's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Current Fresenius Medical Last Dividend Paid | 1.19 |
Most of Fresenius Medical's fundamental indicators, such as Last Dividend Paid, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresenius Medical Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition |
Based on the recorded statements, Fresenius Medical Care has a Last Dividend Paid of 1.19. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The last dividend paid for all United States stocks is notably lower than that of the firm.
Fresenius Last Dividend Paid Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fresenius Medical's direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fresenius Medical could also be used in its relative valuation, which is a method of valuing Fresenius Medical by comparing valuation metrics of similar companies.Fresenius Medical is currently under evaluation in last dividend paid category among related companies.
Fresenius Fundamentals
Return On Equity | 0.0484 | ||||
Return On Asset | 0.0273 | ||||
Profit Margin | 0.03 % | ||||
Operating Margin | 0.1 % | ||||
Current Valuation | 17.43 B | ||||
Shares Outstanding | 586.83 M | ||||
Shares Owned By Institutions | 7.00 % | ||||
Number Of Shares Shorted | 1.1 M | ||||
Price To Earning | 6.53 X | ||||
Price To Book | 0.74 X | ||||
Price To Sales | 0.57 X | ||||
Revenue | 19.45 B | ||||
Gross Profit | 5.31 B | ||||
EBITDA | 3.44 B | ||||
Net Income | 499 M | ||||
Cash And Equivalents | 362.77 M | ||||
Cash Per Share | 1.75 X | ||||
Total Debt | 12.05 B | ||||
Debt To Equity | 0.88 % | ||||
Current Ratio | 1.18 X | ||||
Book Value Per Share | 46.42 X | ||||
Cash Flow From Operations | 2.63 B | ||||
Short Ratio | 2.05 X | ||||
Earnings Per Share | 0.91 X | ||||
Price To Earnings To Growth | 0.39 X | ||||
Target Price | 18.6 | ||||
Number Of Employees | 119.84 K | ||||
Beta | 0.93 | ||||
Market Capitalization | 11.47 B | ||||
Total Asset | 33.93 B | ||||
Retained Earnings | 10.92 B | ||||
Working Capital | 2.59 B | ||||
Current Asset | 6.98 B | ||||
Current Liabilities | 4.19 B | ||||
Annual Yield | 0.03 % | ||||
Five Year Return | 1.29 % | ||||
Net Asset | 33.93 B | ||||
Last Dividend Paid | 1.19 |
About Fresenius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fresenius Medical Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius Medical Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Fresenius Medical Piotroski F Score and Fresenius Medical Altman Z Score analysis. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Fresenius Stock analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Fresenius Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fresenius Medical. If investors know Fresenius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fresenius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Fresenius Medical Care is measured differently than its book value, which is the value of Fresenius that is recorded on the company's balance sheet. Investors also form their own opinion of Fresenius Medical's value that differs from its market value or its book value, called intrinsic value, which is Fresenius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fresenius Medical's market value can be influenced by many factors that don't directly affect Fresenius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fresenius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fresenius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fresenius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.